The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age

S. Gower, A.E. Bartu, Kenneth Ilett, Dorota Doherty, R. Mclaurin, D. Hamilton

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital. Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation. Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours. Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Further research using larger samples to assess possible developmental effects over longer periods of time is required. © The Author(s) 2014.
Original languageEnglish
Pages (from-to)217-223
JournalJournal of Human Lactation
Volume30
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Buprenorphine
Human Milk
Skin Pigmentation
Feeding Behavior
Sleep
Methadone
Documentation
Opioid Analgesics
Mothers
Observation
Parturition
Drug Therapy

Cite this

Gower, S. ; Bartu, A.E. ; Ilett, Kenneth ; Doherty, Dorota ; Mclaurin, R. ; Hamilton, D. / The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age. In: Journal of Human Lactation. 2014 ; Vol. 30, No. 2. pp. 217-223.
@article{3edd19ab6c8546909a56d089ff4a81c5,
title = "The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age",
abstract = "Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital. Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation. Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours. Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Further research using larger samples to assess possible developmental effects over longer periods of time is required. {\circledC} The Author(s) 2014.",
author = "S. Gower and A.E. Bartu and Kenneth Ilett and Dorota Doherty and R. Mclaurin and D. Hamilton",
year = "2014",
doi = "10.1177/0890334413517748",
language = "English",
volume = "30",
pages = "217--223",
journal = "Journal of Human Lactation",
issn = "0890-3344",
publisher = "SAGE Publications Ltd",
number = "2",

}

The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age. / Gower, S.; Bartu, A.E.; Ilett, Kenneth; Doherty, Dorota; Mclaurin, R.; Hamilton, D.

In: Journal of Human Lactation, Vol. 30, No. 2, 2014, p. 217-223.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age

AU - Gower, S.

AU - Bartu, A.E.

AU - Ilett, Kenneth

AU - Doherty, Dorota

AU - Mclaurin, R.

AU - Hamilton, D.

PY - 2014

Y1 - 2014

N2 - Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital. Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation. Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours. Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Further research using larger samples to assess possible developmental effects over longer periods of time is required. © The Author(s) 2014.

AB - Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital. Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation. Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours. Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Further research using larger samples to assess possible developmental effects over longer periods of time is required. © The Author(s) 2014.

U2 - 10.1177/0890334413517748

DO - 10.1177/0890334413517748

M3 - Article

VL - 30

SP - 217

EP - 223

JO - Journal of Human Lactation

JF - Journal of Human Lactation

SN - 0890-3344

IS - 2

ER -